Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label memantine trial for PTSD
jRCTs031180200Completed
- Sponsor
- Grant-in-Aid for Scientific Research
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of memantine in post-traumatic stress disorder (PTSD), major depressive disorder (MDD) and anxiety disorder, sponsored by Grant-in-Aid for Scientific Research. Primary endpoint: PTSD diagnostic status and severity. Started Aug 2016; status: completed.
02
Drugs
memantine
03
Conditions
post-traumatic stress disorder (PTSD)major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on jRCTs031180200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180200.